Found 28 matching trials
Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC PHASE2 Open-label, single-arm, prospective multicenter phase II clinical trial to ...
Show More Location
University Hospital Augsburg, Radiation Oncology
Learn More & Join Trial
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer PHASE2 The purpose of this study is to see if this combination of chemotherapy plu...
Show More Location
Gainsville Hematology Oncology Associates
Learn More & Join Trial
Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC PHASE2 This is a Phase 2 clinical intervention trial to assess efficacy of inducti...
Show More Location
Antoni van Leeuwenhoek ziekenhuis
Learn More & Join Trial
Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT PHASE2 Phase II study of definitive concurrent chemoradiotherapy follows consolida...
Show More Location
Multiple Locations
Learn More & Join Trial
Vertebral Marrow Attention Trial (VMAT) NA The purpose of this study is to see whether designing radiation to spare th...
Show More Location
Vanderbilt-Ingram Service for Timely Access
Learn More & Join Trial
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer PHASE2 This study will enroll patients with locally advanced non-small cell lung c...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer PHASE3 Consolidative immunotherapy following concurrent chemoradiotherapy, based o...
Show More Location
Sun yat-sen University Cancer Center
Learn More & Join Trial
A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer PHASE2 This study will enroll patients with limited-stage small cell lung cancer (...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC PHASE2 This is a single-armed, multicenter, non-blinded phase 2 study to assess ef...
Show More Status
Active Not Recruiting
Location
Antoni van Leeuwenhoek ziekenhuis
Learn More & Join Trial
Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC PHASE1 This Phase 1 trial aimed to determine the maximum tolerated fraction dose (...
Show More Location
Sun yat-sen University Cancer Center
Learn More & Join Trial